Eisenbrey J R, Huang P, Hsu J, Wheatley M A
School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, United States.
Ultrasonics. 2009 Dec;49(8):628-33. doi: 10.1016/j.ultras.2009.03.003. Epub 2009 Mar 28.
Traditional chemotherapy generally results in systemic toxicity, which also limits drug levels at the area of need. Two ultrasound contrast agents (UCA), with diameters between 1-2 microm in diameter and shell thicknesses of 100-200 nm, composed of poly lactic-acid (PLA), one loaded by surface adsorption and the other loaded by drug incorporation in the shell, were compared in vitro for potential use in cancer therapy. These poly lactic-acid (PLA) UCA platforms contain a gas core that in an ultrasound (US) field can cause the UCA to oscillate or rupture. Following a systemic injection of drug loaded UCA with external application of US focused at the area of interest, this platform could potentially increase drug toxicity at the area of need, while protecting healthy tissue through microencapsulation of the drug. In vitro toxicity in MDA-MB-231 breast cancer cells of the surface-adsorbed and shell-incorporated doxorubicin (Dox) loaded UCA were examined at 5 MHz insonation using a pulse repetition frequency of 100 Hz at varying pressure amplitudes. Both platforms resulted in equivalent cell death compared to free Dox and US when insonated at peak positive pressure amplitudes of 1.26 MPa and above. While no significant changes in cell death were seen for surface adsorbed Dox-UCA with or without insonation, cell death using the platform with Dox incorporated within the shell increased from 16.12% to 25.78% (p=0.0272), approaching double the potency of the platform when insonated at peak positive pressure amplitudes of 1.26 MPa and above. This mechanism is believed to be the result of UCA rupture at higher insonation pressure amplitudes, resulting in more exposed drug and shell surface area as well as increased cellular uptake of Dox containing polymer shell fragments. This study has shown that a polymer UCA with drug housed within the shell may be used for US-triggered cell death. US activation can be used to make a carrier significantly more potent once in the area of need.
传统化疗通常会导致全身毒性,这也限制了所需部位的药物浓度。比较了两种由聚乳酸(PLA)组成的超声造影剂(UCA),其直径在1-2微米之间,壳厚度为100-200纳米,一种通过表面吸附加载药物,另一种通过将药物掺入壳中加载药物,以评估其在癌症治疗中的潜在用途。这些聚乳酸(PLA)UCA平台包含一个气体核心,在超声(US)场中可使UCA振荡或破裂。在全身注射载药UCA并在感兴趣区域外部施加聚焦超声后,该平台可能会增加所需部位的药物毒性,同时通过药物微囊化保护健康组织。使用5MHz的超声频率、100Hz的脉冲重复频率和不同的压力幅度,检测了表面吸附和壳内掺入阿霉素(Dox)的载药UCA对MDA-MB-231乳腺癌细胞的体外毒性。当在1.26MPa及以上的峰值正压幅度下进行超声照射时,与游离Dox和超声相比,两种平台导致的细胞死亡相当。虽然表面吸附的Dox-UCA在有无超声照射时细胞死亡均无显著变化,但壳内掺入Dox的平台导致的细胞死亡从16.12%增加到25.78%(p=0.0272),在1.26MPa及以上的峰值正压幅度下进行超声照射时,其效力接近该平台的两倍。据信,这种机制是由于在较高的超声压力幅度下UCA破裂,导致更多的药物和壳表面积暴露,以及含Dox的聚合物壳碎片的细胞摄取增加。这项研究表明,壳内含有药物的聚合物UCA可用于超声触发的细胞死亡。一旦到达所需部位,超声激活可使载体的效力显著增强。